Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 05-Jun-23 4:37 PM View:  | Tcr2 Therapeutics Inc. (TCRR) | 01-Jun-23 | Disposition (other) | 3,370,980 | -- | -- | (100%) 3.37M to 0 | |
| 20-Sep-21 5:31 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 16-Sep-21 | Market Sale (Planned) | 3,124 | $29.06 | $90,783.40 | (< 1%) 7.65M to 7.65M | 9% |
| 16-Sep-21 4:45 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 15-Sep-21 | Market Sale (Planned) | 6,425 | $29.16 | $187,353.00 | (< 1%) 7.66M to 7.65M | < 1% |
| 16-Sep-21 4:45 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 14-Sep-21 | Market Sale (Planned) | 7,106 | $29.17 | $207,282.00 | (< 1%) 7.66M to 7.66M | < 1% |
| 13-Sep-21 6:24 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 13-Sep-21 | Market Sale (Planned) | 3,595 | $29.10 | $104,614.00 | (< 1%) 7.67M to 7.66M | < 1% |
| 13-Sep-21 6:24 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 10-Sep-21 | Market Sale (Planned) | 5,931 | $29.04 | $172,236.00 | (< 1%) 7.67M to 7.67M | < 1% |
| 13-Sep-21 6:24 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 09-Sep-21 | Market Sale (Planned) | 13,727 | $29.35 | $402,887.00 | (< 1%) 7.69M to 7.67M | 2% |
| 08-Sep-21 6:20 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 08-Sep-21 | Market Sale (Planned) | 10,842 | $29.11 | $315,611.00 | (< 1%) 7.7M to 7.69M | < 1% |
| 08-Sep-21 6:20 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 07-Sep-21 | Market Sale (Planned) | 25,067 | $29.04 | $727,946.00 | (< 1%) 7.72M to 7.7M | < 1% |
| 08-Sep-21 6:20 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 03-Sep-21 | Market Sale (Planned) | 12,731 | $29.60 | $376,838.00 | (< 1%) 7.74M to 7.72M | 2% |
| 02-Sep-21 5:26 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 02-Sep-21 | Market Sale (Planned) | 15,757 | $29.46 | $464,201.00 | (< 1%) 7.75M to 7.74M | (< 1%) |
| 02-Sep-21 5:26 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 01-Sep-21 | Market Sale (Planned) | 5,714 | $29.47 | $168,392.00 | (< 1%) 7.76M to 7.75M | (< 1%) |
| 02-Sep-21 5:26 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 31-Aug-21 | Market Sale (Planned) | 2,838 | $29.82 | $84,625.00 | (< 1%) 7.76M to 7.76M | < 1% |
| 31-Aug-21 4:47 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 30-Aug-21 | Market Sale (Planned) | 31,001 | $29.30 | $908,329.00 | (< 1%) 7.79M to 7.76M | (< 1%) |
| 31-Aug-21 4:47 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 27-Aug-21 | Market Sale (Planned) | 13,357 | $29.09 | $388,555.00 | (< 1%) 7.81M to 7.79M | (2%) |
| 25-Aug-21 7:42 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 25-Aug-21 | Market Sale (Planned) | 1,713 | $29.09 | $49,831.20 | (< 1%) 7.81M to 7.81M | |
| 25-Aug-21 7:42 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 24-Aug-21 | Market Sale (Planned) | 50,822 | $29.48 | $1,498,230.00 | (< 1%) 7.86M to 7.81M | 10% |
| 25-Aug-21 7:42 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 23-Aug-21 | Market Sale (Planned) | 53,359 | $29.11 | $1,553,280.00 | (< 1%) 7.91M to 7.86M | 9% |
| 14-Jan-21 5:54 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 12-Jan-21 | Conversion | 7,613,890 | -- | -- | 100% 0 to 7.61M | |
| 14-Jan-21 5:54 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 12-Jan-21 | Purchase | 300,000 | $21.00 | $6,300,000.00 | 4% 7.61M to 7.91M | |
| 08-Oct-20 6:26 PM View: | Oncorus, Inc. (ONCR) | 06-Oct-20 | Conversion | 2,225,800 | -- | -- | 100% 0 to 2.23M | |
| 08-Oct-20 6:26 PM View: | Oncorus, Inc. (ONCR) | 06-Oct-20 | Purchase | 151,224 | $15.00 | $2,268,360.00 | 7% 2.23M to 2.38M | |
| 21-Feb-19 6:06 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 19-Feb-19 | Conversion | 2,704,320 | -- | -- | 100% 0 to 2.7M | |
| 21-Feb-19 6:06 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 19-Feb-19 | Purchase | 666,667 | $15.00 | $10,000,000.00 | 25% 2.7M to 3.37M | |
| 14-Feb-19 5:34 PM View: | Harpoon Therapeutics, Inc. (HARP) | 12-Feb-19 | Conversion | 3,521,770 | -- | -- | 100% 0 to 3.52M | |
| 14-Feb-19 5:34 PM View: | Harpoon Therapeutics, Inc. (HARP) | 12-Feb-19 | Purchase | 250,000 | $14.00 | $3,500,000.00 | 7% 3.52M to 3.77M | |
| 14-Feb-19 5:34 PM View: | Harpoon Therapeutics, Inc. (HARP) | 12-Feb-19 | Sale | 447 | $14.00 | $6,258.00 | (< 1%) 3.9M to 3.9M | |
| 14-Feb-19 5:34 PM View: | Harpoon Therapeutics, Inc. (HARP) | 12-Feb-19 | Exercise (in-the money or at-the-money) | 127,096 | $0.05 | $6,253.12 | 3% 3.77M to 3.9M |